RalBP1 is necessary for metastasis of human cancer cell lines

Zhong Wu1, Charles Owens, Nidhi Chandra

  • 1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.

Neoplasia (New York, N.Y.)
|December 21, 2010
PubMed

Insights

RalA and Ral binding protein 1 (RalBP1) are crucial for human cancer cell migration and metastasis. RalBP1 is essential for metastasis in prostate and bladder cancers, independent of its direct interaction with RalA.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • RalA protein expression in human prostate cancer correlates with cell migration and bone metastasis.
  • The specific downstream targets of RalA that drive these metastatic processes are not fully understood.

Purpose of the Study:

  • To investigate the roles of RalA effectors, specifically Ral binding protein 1 (RalBP1), exocyst complex component 2 (Sec5), and phospholipase D1 (PLD1), in cancer cell migration and metastasis.
  • To determine if RalBP1 is essential for metastasis in cancers beyond prostate cancer.

Main Methods:

  • Small interfering RNA (siRNA) and short hairpin RNA (shRNA) were used to deplete RalA and its effectors in human prostate cancer (PC3) and bladder cancer (UMUC3) cell lines.
  • In vivo studies involved intracardiac inoculation of PC3 cells to assess bone metastasis and orthotopic implantation to evaluate tumor growth and spontaneous metastasis.
  • Experimental metastasis models were used to study lung colonization of UMUC3 cells.

Main Results:

  • Depletion of RalA and RalBP1 significantly inhibited prostate cancer cell migration and bone metastasis.
  • RalBP1 depletion reduced orthotopic tumor growth and spontaneous metastasis of PC3 cells.
  • RalBP1 depletion decreased lung colonization in a bladder cancer metastasis model, while having minimal impact on subcutaneous tumor growth.
  • Restoring RalA expression with wild-type or RalBP1-binding deficient mutants partially rescued the metastatic capacity of RalA-depleted cells, indicating RalA's function is not solely dependent on RalBP1 interaction.

Conclusions:

  • Ral binding protein 1 (RalBP1) is a critical mediator of human cancer cell metastasis in both prostate and bladder cancer.
  • RalA's role in promoting metastasis is not entirely dependent on its interaction with RalBP1.
  • RalBP1 represents a potential therapeutic target for inhibiting cancer metastasis.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...